Delcath Systems (DCTH) Total Debt (QoQ) (2011 - 2024)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Delcath Systems | 383.27 Mn | 293.95 Mn | 21.26 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | -54.04% |
| Dec 31, 2023 | 3.13% |
| Sep 30, 2023 | 3.23% |
| Jun 30, 2023 | 3.34% |
| Mar 31, 2023 | -56.38% |
| Dec 31, 2022 | -42.90% |
| Sep 30, 2022 | 69.02% |
| Jun 30, 2022 | 1.43% |
| Mar 31, 2022 | 1.46% |
| Dec 31, 2021 | -13.02% |
| Dec 31, 2019 | -83.50% |
| Sep 30, 2019 | 226,677.78% |
| Jun 30, 2019 | -65.38% |
| Mar 31, 2019 | -21.21% |
| Dec 31, 2018 | -97.76% |
| Sep 30, 2018 | -78.57% |
| Jun 30, 2018 | 65.10% |
| Mar 31, 2018 | 644.46% |
| Dec 31, 2017 | 3,400.00% |
| Sep 30, 2017 | -62.79% |
| Jun 30, 2017 | -99.75% |
| Mar 31, 2017 | -6.60% |
| Dec 31, 2016 | -16.67% |
| Sep 30, 2016 | -27.83% |
| Jun 30, 2016 | 1,420.28% |
| Mar 31, 2016 | -45.81% |
| Dec 31, 2015 | 28.96% |
| Sep 30, 2015 | 285.68% |
| Jun 30, 2015 | -8.97% |
| Mar 31, 2015 | 271.56% |
| Dec 31, 2014 | -59.46% |
| Sep 30, 2014 | -48.37% |
| Jun 30, 2014 | -55.19% |
| Mar 31, 2014 | 3.85% |
| Dec 31, 2013 | 167.67% |
| Sep 30, 2013 | 135.79% |
| Jun 30, 2013 | -93.33% |
| Mar 31, 2013 | 60.05% |
| Dec 31, 2012 | -24.86% |
| Sep 30, 2012 | -22.89% |
| Jun 30, 2012 | 101.88% |
| Mar 31, 2012 | 20.13% |
| Dec 31, 2011 | -22.35% |
| Sep 30, 2011 | -55.21% |